Skip to content

Study · Case report or series · n = 1 · 2025

2 results

Semaglutide-Induced Liver Injury.

Kalsi H, Arora SS, Essilfie-Quaye K, Bassi R, Akhavan N, Perbtani Y, Brar TS

ACG case reports journal4 Aug 2025Cited by 2 (Europe PMC)

PMID40761336 (opens in a new tab)PMCIDPMC12321452 (opens in a new tab)DOI10.14309/crj.0000000000001776 (opens in a new tab)PepBankPUB-40761336
Read at sourcePubMedAsk about this study
Jump to 2 results

Summary

The text of this summary is not shown here, because the article license does not allow reuse. Read it at the source (opens in a new tab)

Text rights: CC BY-NC-ND. Results still quote short attributed sentences.

Results from this study2

2 results from studies that gave the peptide. 2 results from people.

  1. 01HumanCase report or seriesSafety outcome

    In a 44-year-old woman, liver enzymes were elevated after semaglutide was started for weight management.

    In plain wordsIn one 44-year-old woman, liver enzymes rose after she started semaglutide for weight management.

    Peptide
    Semaglutide
    Outcome
    IncreaseLiver enzymes after semaglutide initiation
    Study

    n = 1

    Outcome group
    Liver fat and liver function · Liver
    Studied dose
    Dose not stated

    Source sentences

    Summary
    We detail a case of a 44-year-old woman who developed liver injury with elevated liver enzymes after semaglutide initiation for weight management.
  2. 02HumanCase report or seriesSafety outcome

    In the same woman, liver enzyme levels normalized after semaglutide was stopped and worsened on rechallenge.

    In plain wordsIn this one woman, liver enzymes returned to normal when semaglutide was stopped and got worse when it was restarted.

    Peptide
    Semaglutide
    Outcome
    MixedLiver enzymes after dechallenge and rechallenge
    Study

    n = 1

    Outcome group
    Liver fat and liver function · Liver
    Studied dose
    Dose not stated

    Source sentences

    Summary
    Liver enzyme levels normalized after discontinuing the drug and worsened upon rechallenge, confirming semaglutide's potential to cause liver injury.
    1 context sentence
    Summary · context
    We detail a case of a 44-year-old woman who developed liver injury with elevated liver enzymes after semaglutide initiation for weight management.

AI wrote and checked these results. AI can make mistakes, so check important results against the source.

Version history

PepBank keeps every version of the data on this study. Status changes from Retraction Watch, Europe PMC and Crossref are listed with their source.

  1. Version 2Current

    11 Oct 2026, 00:04 UTC

    Study results updated

  2. Version 1

    9 Oct 2026, 03:06 UTC

    First added · source update from Europe PMC

Subjects

Terms as the source lists them.

PepBank is a research reference. Talk to a doctor before you use any peptide.